TICKERNERD
Menu
ACAACAIndustrials · Engineering & Construction

ACA Stock Forecast: Arcosa, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$145
−0.17% on the day

The 3 Wall Street analysts covering Arcosa, Inc. hold a median 12-month price target of $150 — +3.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 51 of 100 as at 12 Sept 2026 — in the upper half.

Market cap
$7.1B
Ticker Nerd rank
51 / 100
Median analyst target
$150
Analysts covering
3
Revenue$658.7M−10.6% y/y
Operating income$84.3M
Net income$328.5M
Free cash flow−$70.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.3%
1M
+0.1%
YTD
+36.5%
1Y
+48.0%
From 52W high
−0.4%
From 52W low
+62.9%
$89
$146
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ACA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Arcosa, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
51 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
95
Issuance
92
Volatility
66
Accruals
57
Revisions
49
Growth
46
Quality
35
Value
19
Size
19

Momentum (95): The shares have been drifting up relative to others.

Value (19): The shares cost a lot relative to the profits and assets behind them.

Size (19): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ACA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ACA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$90$100$110$120$130$140$150Oct 25Jan 26Apr 26Jul 26ACAHigh $150Median $150Low $140

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
1 Buy2 Hold0 Sell
Low $140Median $150High $150

The green dot is the last close — the median target sits +3.4% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
28 May 2026OppenheimerAssumesOutperform$150
4 May 2026BarclaysMaintainsOverweight—
2 Mar 2026DA DavidsonMaintainsBuy—
3 Nov 2025BarclaysMaintainsOverweight—
11 Aug 2025DA DavidsonMaintainsBuy—
14 Jan 2025OppenheimerMaintainsOutperform—
29 Oct 2024BarclaysInitiatesOverweight—
19 Aug 2024OppenheimerMaintainsOutperform—
7 Aug 2024Stephens & Co.UpgradeOverweight—
17 May 2024DA DavidsonMaintainsBuy—
6 May 2024DA DavidsonMaintainsBuy—
28 Feb 2024DA DavidsonMaintainsBuy—
23 Feb 2024OppenheimerMaintainsOutperform—
17 Oct 2023Sidoti & Co.UpgradeBuy—
8 Aug 2023Stephens & Co.MaintainsEqual-Weight—
7 Aug 2023DA DavidsonMaintainsBuy—
7 Aug 2023Loop CapitalMaintainsBuy—
8 May 2023OppenheimerMaintainsOutperform—
1 May 2023DA DavidsonMaintainsBuy—
1 May 2023Loop CapitalMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ACA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ACA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Arcosa, Inc. returned +48.0% against +17.5% for the S&P 500, dividends included.

ACA vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140150Oct 25Jan 26Apr 26Jul 26ACAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ACA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.1%
Analysts raising
0
Analysts cutting
2
Fundamentals

Arcosa, Inc. (ACA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
32.4×

Cheaper than 23% of US stocks

Price / sales
2.4×

Cheaper than 47% of US stocks

Price / book
2.4×

Cheaper than 40% of US stocks

EV / EBITDA
14.9×

Cheaper than 23% of US stocks

Growth & margins
Revenue growth (YoY)
1.7%

Higher than 31% of US stocks

Earnings growth (YoY)
450.3%

Higher than 95% of US stocks

Gross margin
23.6%

Higher than 26% of US stocks

Operating margin
12.3%

Higher than 68% of US stocks

Net margin
16.8%

Higher than 80% of US stocks

Returns & dividend
Return on equity
8.0%

Higher than 59% of US stocks

Return on assets
3.9%

Higher than 70% of US stocks

Dividend yield
0.1%

Higher than 2% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Arcosa, Inc. (ACA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Arcosa, Inc. has a market value of $7.1B and an enterprise value of $8.2B.

  • Revenue in the twelve months to 30 June 2026: $2.7B. The latest quarter grew 1.7% year on year.

  • Net income over the same four quarters: $491.4M, a 17.9% net margin.

  • Diluted earnings per share, trailing twelve months: $9.98.

  • Free cash flow in the twelve months to 30 June 2026: $133.4M, after $207.9M of capital spending.

  • Arcosa, Inc. spent $31.8M on share buybacks and $9.9M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 49.1M.

  • Trailing P/E: 32.4×; forward P/E: 28.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.14%, paying out 4% of earnings.

  • Arcosa, Inc. employs 6,390 people — $430K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

ACA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelEngineering & Construction
CompanyMarket capTKN rank
ACAArcosa, Inc.$7.1B
51
FLRFluor Corp.$7.2B
65
LGNLegence Corp.$6.1B
29
ECGEverus Construction Group, Inc.$6.1B
91
ACMAECOM$8.4B
37
AGXArgan, Inc.$5.8B
97
ROADConstruction Partners, Inc.$5.6B
73

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Arcosa, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ACA news & analysis

Arcosa Stockholders Approve Acquisition by CRH

Business Wire · 4 Sept 2026neutral

Arcosa, Inc. announced that its stockholders approved the acquisition by CRH at a special meeting held on September 4, 2026. The company will disclose the final certified voting results on a Form 8-K with the U.S. Securities and Exchange Commission, under a previously announced merger agreement for CRH to acquire 100% of Arcosa.

Why it matters — This approval is a key procedural step toward the completion of CRH's planned acquisition of Arcosa, which will result in the company being taken over and delisted.

Arcosa, Inc. Declares Quarterly Dividend

Business Wire · 2 Sept 2026neutral

Arcosa, Inc.'s Board of Directors declared a regular quarterly cash dividend of $0.05 per share on its common stock. The dividend is payable on October 30, 2026, to shareholders of record as of October 15, 2026.

Why it matters — This announcement provides ACA shareholders with confirmation of an upcoming cash distribution and the associated record and payment dates.

Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA

Business Wire · 17 Aug 2026negative

Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti Jr., is investigating the proposed sale of Arcosa, Inc. to CRH, under which Arcosa shareholders would receive $150.00 in cash per share. The firm is examining whether the consideration and the process leading to it are adequate.

Why it matters — An investor-law firm investigation signals potential scrutiny of the proposed acquisition's terms and process, which ACA shareholders would want to monitor.

Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?

Zacks Investment Research · 7 Aug 2026neutral

Zacks reports that CRH's $8.5 billion deal for Arcosa could expand its exposure to U.S. aggregates and energy infrastructure, while noting financing and integration risks. The deal involves potential risks alongside the expansion opportunity.

Why it matters — ACA watchers would care because the report highlights the potential scope and risks of CRH's acquisition of Arcosa, affecting the company's future positioning in U.S. aggregates and energy infrastructure.

Arcosa (ACA) Q2 Earnings and Revenues Lag Estimates

Zacks Investment Research · 6 Aug 2026negative

Arcosa reported second-quarter earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.18 per share and falling from $1.27 per share in the same quarter a year ago. Revenues also lagged estimates.

Why it matters — A missed earnings estimate and year-over-year earnings decline signal weaker-than-expected quarterly performance for Arcosa, which ACA watchers would track closely.

FAQ

Frequently asked questions about ACA stock

What is the ACA stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Arcosa, Inc. have a median 12-month price target of $150, with estimates ranging from $140 to $150. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ACA stock a buy right now?

Of the 3 analysts covering Arcosa, Inc., 1 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Arcosa, Inc. 51 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ACA?

As at 12 Sept 2026, Arcosa, Inc. ranks 51 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (95 of 100).

Will ACA stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +3.4% from the last close, and Ticker Nerd's factor model ranks Arcosa, Inc. 51 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ACA stock forecast for 2030?

No analyst covering Arcosa, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ACA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $140 to $150 over the next 12 months.

How has ACA stock performed over the past year?

Arcosa, Inc. returned +48.0% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Arcosa, Inc. do?

Arcosa, Inc. is an infrastructure-focused industrial company that provides products and solutions for construction, engineered structures, and transportation markets.

What is the latest news on ACA?

The most recent item we track (Business Wire, 4 Sept 2026): "Arcosa Stockholders Approve Acquisition by CRH". Arcosa, Inc. announced that its stockholders approved the acquisition by CRH at a special meeting held on September 4, 2026. The company will disclose the final certified voting results on a Form 8-K with the U.S. Securities and Exchange Commission, under a previously announced merger agreement for CRH to acquire 100% of Arcosa.

Company

About Arcosa, Inc.

Arcosa, Inc. is an infrastructure-focused industrial company that provides products and solutions for construction, engineered structures, and transportation markets. Its Construction Products segment supplies natural and recycled aggregates, specialty materials, and trench shoring and shielding products used in infrastructure, residential, and non-residential projects. The Engineered Structures segment produces utility structures, wind towers, traffic and lighting structures, and telecommunication structures that support power transmission, renewable energy, roadway systems, and communications networks. The Transportation Products segment manufactures inland barges, marine hardware, and related equipment for commercial marine transportation and industrial customers. Arcosa serves contractors, utilities, telecom providers, transportation operators, and public infrastructure customers across North America, making it an important supplier in markets tied to building, moving, and maintaining critical infrastructure.

CEO Mr. Antonio Carrillo Rule · 6,390 employees · United States · https://www.arcosa.com